Healthcare Health/Fitness

AstraZeneca

AstraZeneca CEO says new Pfizer bid unlikely

U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca, the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business daily Dagens Industri on Saturday.

Read Full Article
IPO

Wristband maker Fitbit in talks with banks for IPO

Fitness tracking wristband maker Fitbit Inc is in talks with banks for its initial public offering in the United States, Bloomberg reported, citing people familiar with the matter.

Read Full Article
Smoker smoking an e-cigarette

Cigarette smoking costs weigh heavily on the healthcare system

Of every $10 spent on healthcare in the U.S., almost 90 cents is due to smoking, a new analysis says. Using recent health and medical spending surveys, researchers calculated that 8.7 percent of all healthcare spending, or $170 billion a year, is for illness caused by tobacco smoke, and public programs like Medicare and Medicaid paid for most of these costs.

Read Full Article
ObamaCare Website

Obamacare helps private equity get its rehab clinic fix

Investors are pouring money into the operators of U.S. rehab centers as many more Americans get health care coverage for addiction treatment, driving up valuations and triggering a consolidation of businesses in the fragmented sector.

Read Full Article
GlaxoSmithKline

GSK to axe U.S. jobs as part of $1.6 billion cost cuts: sources

GlaxoSmithKline will this week inform U.S. staff of hundreds of job cuts in its biggest market as the drugmaker starts implementing a major cost-saving program, sources familiar with the matter said on Sunday.

Read Full Article
Merck KGaA

Germany's Merck aims to grow, not sell $1 billion consumer health arm

Merck KGaA (MRCG.DE) aims to keep hold of its consumer healthcare unit, it said on Friday, pledging to develop a business that is expected to generate 2014 sales of $1 billion for the German drugs and chemicals company.

Read Full Article
Medibank Private

Australia's Medibank IPO prices at A$2.15 a share, raising A$5.7 billion

Australia said on Sunday it would list state-owned health insurer Medibank Private Ltd (MPL.AX) with a market capitalization of A$5.679 billion ($4.9 billion), exceeding the top end of a range indicated in its IPO filing a month earlier.

Read Full Article
First aid kit

J&J seeks over $5 billion in damages from Boston Scientific at trial

Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

Read Full Article
Ebola

Chinese team arrives in Liberia to staff Ebola clinic

About 160 Chinese health workers arrived on Saturday in Liberia, where they are due to staff a new $41 million Ebola clinic that, unlike most other foreign interventions, is being built and fully run by Chinese personnel.

Read Full Article
Obamacare

Obamacare enters new phase over the weekend with little fanfare

President Barack Obama's plan to extend private health coverage to the uninsured entered a new uncertain phase on Saturday as U.S. government-backed online insurance marketplaces opened their 2015 plans to millions of potential enrollees.

Read Full Article
Aurobindo Pharma logo

India's Aurobindo to buy U.S. nutritional supplements maker for $133 million

Indian generic drugmaker Aurobindo Pharma Ltd (ARBN.NS) said on Wednesday its U.S. unit won a bankruptcy auction to buy nutritional supplements maker Natrol Inc for $132.5 million.

Read Full Article
Obamacare

U.S. releases low 2015 Obamacare enrollment forecast

The U.S. administration on Monday dramatically cut expectations for 2015 Obamacare enrollment, saying it aims to have a total of 9.1 million people enrolled in government-backed federal and state health insurance marketplaces next year.

Read Full Article
Healthcare

Quest says content with diagnostics, does not need CRO

The chief executive of Quest Diagnostics Inc (DGX.N) said his company will stick to its core business of diagnostic testing and is not interested in acquiring a contract research organization (CRO), despite such a planned move by rival diagnostics firm LabCorp (LH.N).

Read Full Article
Thermo Fisher

Thermo Fisher pledges to fix glitch in drug analysis software

Thermo Fisher Scientific has pledged to correct a glitch in software used to analyze data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors.

Read Full Article
Pfizer

Pfizer beats sales and profit forecasts, mum on future deals

Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans following its recent failed efforts to buy rival British drugmaker AstraZeneca Plc (AZN.L).

Read Full Article
1 2 3 4 5 6 7 8 9 10  

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics